| Catalog Number |
03L82-21 |
| Medical Device Problem Code |
High Test Results (2457)
|
| Health Effect - Clinical Code |
No Known Impact Or Consequence To Patient (2692)
|
| Date of Event |
10/04/2019
|
|
Type of Reportable Event
|
Malfunction
|
|
Additional Manufacturer Narrative
|
|
An evaluation is in process.A follow-up report will be submitted when the evaluation is complete.There is no further patient information provided due to privacy issues.
|
| |
|
Event or Problem Description
|
|
The customer reported falsely elevated glucose results on one patient generated on the architect analyzer.The results provided were: on (b)(6) 2019 (b)(6) initial = 282.7mg/dl / repeated on (b)(6) 2019 = 92mg/dl / hba1c = 5.5; new sample on (b)(6) 2019 (b)(6)= 82.2mg/dl.There was no reported impact to patient management.
|
| |
|
Additional Manufacturer Narrative
|
|
A review of tickets for lot 54742uq04 did not find any additional complaints and no trends were identified for the product issue.Return testing was not completed as returns were not available.A review of the architect, serial number (b)(6), instrument logs did not find the data provided by the customer.A review of the manufacturing documentation did not identify any issues associated with the customer's observation.A review of the product labeling concluded that the issue is sufficiently addressed.Based on our investigation no product deficiency was identified for the clin chem glucose, lot 54742uq04.
|
| |
|
Search Alerts/Recalls
|